| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical agent applicable for post-treatment recurrent hepatocellular carcinoma inhibition and containing peretinoin combined with L-isoleucine, L-leucine and L-valine.EFFECT: invention provides the effective post-treatment recurrent hepatocellular carcinoma inhibition.20 cl, 1 ex, 1 tbl, 1 dwg |
